*Sydney Medical School, University of Sydney
‡National Drug and Alcohol Research Centre, UNSW Australia, Sydney
†The Langton Centre, South East Sydney Local Health District (SESLHD) Drug and Alcohol Services, Surry Hills, NSW
§School of Medicine, University of Tasmania, Hobart, Tas., Australia
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website, www.clinicalpain.com.
B.L., L.D., S.N., G.C., and N.L. have received untied educational grants from Reckitt Benckiser. B.L., R.B., L.D., and N.L. have received untied educational grants from Mundi Pharma. The funders had no knowledge of this study. They played no role in the studies, their conduct, the write up, or the decision to publish. This study received funding from the Australian National Health and Medical Research Council (NHMRC, #1022522), Canberra, Australia. L.D., B.L., and S.N. are supported by NHMRC research fellowships (#1041472, #1073858, and #1013803), Canberra, Australia. The National Drug and Alcohol Research Centre at the University of NSW is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund, Canberra, Australia. The other authors have no conflict of interest to disclose.
Reprints: Nicholas Lintzeris, PhD, Director, The Langton Centre, South East Sydney Local Health District (SESLHD) Drug and Alcohol Services, 591 South Dowling Street, Surry Hills 2010, NSW, Australia (e-mail: [email protected]).
Received February 3, 2015
Received in revised form August 13, 2015
Accepted July 8, 2015
